Document Detail


Safety and feasibility of autologous umbilical cord blood transfusion in 2 toddlers with cerebral palsy and the role of low dose granulocyte-colony stimulating factor injections.
MedLine Citation:
PMID:  21335665     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Cerebral palsy (CP) with a prevalence of 2.1 per 1,000 live births generates variable degrees of incurable developmental disability. The aim of the present report was to provide insight in the safety and feasibility of autologous umbilical cord blood (UCB) transfusion with low dose Granulocyte Colony Stimulating Factor (G-CSF) injections in improving the functional outcome of children with cerebral palsy.
METHODS: Two toddlers with diagnosed CP were given autologous umbilical cord blood (UCB) transfusion accompanied by low dose subcutaneous granulocyte colony stimulating factor (G-CSF) injections.
RESULTS: Gross Motor Function Classification System (GMFCS) improvements were seen in both without any side effects being noted to date.
CONCLUSION: In this first report, autologous UCB based intervention in tandem with low dose sc G-CSF administration seems to be feasible and safe with encouraging functional outcome improvements in children with CP.
Authors:
Konstantinos I Papadopoulos; Sharon Su Shing Low; Tar Choon Aw; Teerachai Chantarojanasiri
Related Documents :
2741535 - Assessment of arterial and venous circulation in upper and lower extremities by venous ...
21359285 - Establishing a new conductance stopped-flow apparatus to investigate the initial fast s...
7797775 - Absence of vascular tolerance in conductance vessels after 48 hours of intravenous nitr...
3798325 - Extremity blood flow in man: comparison between strain-gauge and capacitance plethysmog...
22091905 - Influence of durotomy on laser-doppler measurement of spinal cord blood flow in chondro...
982775 - Effects of different slaughter methods on bleeding sheep.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Restorative neurology and neuroscience     Volume:  29     ISSN:  0922-6028     ISO Abbreviation:  Restor. Neurol. Neurosci.     Publication Date:  2011  
Date Detail:
Created Date:  2011-02-21     Completed Date:  2012-01-17     Revised Date:  2012-04-05    
Medline Journal Info:
Nlm Unique ID:  9005499     Medline TA:  Restor Neurol Neurosci     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  17-22     Citation Subset:  IM    
Affiliation:
THAI StemLife, 23rd fl., The Offices at Central World, Patumwan, Bangkok, Thailand. kostas@thaistemlife.co.th
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Transfusion, Autologous / adverse effects,  methods*
Cerebral Palsy / drug therapy,  physiopathology,  therapy*
Child, Preschool
Combined Modality Therapy / adverse effects,  methods
Feasibility Studies
Fetal Blood / transplantation*
Granulocyte Colony-Stimulating Factor / administration & dosage*,  adverse effects
Humans
Male
Chemical
Reg. No./Substance:
143011-72-7/Granulocyte Colony-Stimulating Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neuroprotective effects of progesterone and allopregnanolone on long-term cognitive outcome after gl...
Next Document:  Restoration of cognitive deficits after statin feeding in TBI.